Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-17-000446
Filing Date
2017-03-09
Accepted
2017-03-09 14:39:09
Documents
36
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q etbi_10q.htm 10-Q 251325
2 CERTIFICATION etbi_ex311.htm EX-31.1 7223
3 CERTIFICATION etbi_ex312.htm EX-31.2 7253
4 CERTIFICATION etbi_ex321.htm EX-32.1 3373
5 CERTIFICATION etbi_ex322.htm EX-32.2 3435
  Complete submission text file 0001640334-17-000446.txt   1292175

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT etbi-20160630.xml EX-101.INS 126302
7 XBRL TAXONOMY EXTENSION SCHEMA etbi-20160630.xsd EX-101.SCH 19953
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etbi-20160630_cal.xml EX-101.CAL 35464
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etbi-20160630_def.xml EX-101.DEF 34166
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE etbi-20160630_lab.xml EX-101.LAB 138054
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etbi-20160630_pre.xml EX-101.PRE 97174
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

EIN.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52886 | Film No.: 17677950
SIC: 6799 Investors, NEC